Literature DB >> 17204879

Minimally invasive surgery for the management of cervical spondylosis.

Paul Santiago1, Richard G Fessler.   

Abstract

Dorsal surgical procedures have a well-established role in the treatment of both radiculopathy and myelopathy caused by cervical spondylosis. Laminectomy and laminoplasty procedures can both lead to postoperative kyphosis because of the removal of the dorsal supporting structures of the neck. Minimally invasive or minimal-access spinal surgery procedures of the dorsal cervical spine are evolving techniques with the goal of decompressing the neural structures with minimal disruption of the dorsal supporting structures. We think that this will lead to less postoperative pain and a decreased incidence of post-decompression kyphotic deformity. Patient selection, techniques, and results are discussed for both minimally invasive cervical laminoforaminotomy and stenosis decompression.

Entities:  

Mesh:

Year:  2007        PMID: 17204879     DOI: 10.1227/01.NEU.0000215349.40925.88

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

Review 1.  Spontaneous spinal epidural hematoma of unknown etiology: case report and literature review.

Authors:  Robert H Thiele; Ziad A Hage; Daniel L Surdell; Stephen L Ondra; H Hunt Batjer; Bernard R Bendok
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

2.  Applied anatomy of a minimally invasive muscle-splitting approach to posterior C1-C2 fusion: an anatomical feasibility study.

Authors:  Gergely Bodon; Lajos Patonay; Gabor Baksa; Claes Olerud
Journal:  Surg Radiol Anat       Date:  2014-03-02       Impact factor: 1.246

3.  Microscope-assisted anterior cervical discectomy and fusion combined with posterior minimally invasive surgery through tubular retractors for multisegmental cervical spondylotic myelopathy: A retrospective study.

Authors:  Ran-Ze Cai; Yin-Qing Wang; Rui Wang; Chun-Hua Wang; Chun-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.